ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP1
- PMID: 40233740
- PMCID: PMC12085291
- DOI: 10.1016/j.cell.2025.03.019
ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP1
Abstract
Ferroptosis is a form of cell death due to iron-induced lipid peroxidation. Ferroptosis suppressor protein 1 (FSP1) protects against this death by generating antioxidants, which requires nicotinamide adenine dinucleotide, reduced form (NADH) as a cofactor. We initially uncover that NADH exists at significant levels on cellular membranes and then find that this form of NADH is generated by aldehyde dehydrogenase 7A1 (ALDH7A1) to support FSP1 activity. ALDH7A1 activity also acts directly to decrease lipid peroxidation by consuming reactive aldehydes. Furthermore, ALDH7A1 promotes the membrane recruitment of FSP1, which is instigated by ferroptotic stress activating AMP-activated protein kinase (AMPK) to promote the membrane localization of ALDH7A1 that stabilizes FSP1 on membranes. These findings advance a fundamental understanding of NADH by revealing a previously unappreciated pool on cellular membranes, with the elucidation of its function providing a major understanding of how FSP1 acts and how an aldehyde dehydrogenase protects against ferroptosis.
Keywords: aldehyde dehydrogenase 7A1; ferroptosis; ferroptosis suppressor protein 1; nicotinamide adenine dinucleotide reduced form.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests M.C. is a co-founder and shareholder of ROSCUE Therapeutics GmbH.
Similar articles
-
BNIP3-mediated mitophagy attenuates hypoxic-ischemic brain damage in neonatal rats by inhibiting ferroptosis through P62-KEAP1-NRF2 pathway activation to maintain iron and redox homeostasis.Acta Pharmacol Sin. 2025 Jan;46(1):33-51. doi: 10.1038/s41401-024-01365-x. Epub 2024 Aug 23. Acta Pharmacol Sin. 2025. PMID: 39179868
-
NSUN2-mediated cytosine-5 methylation of FSP1 protects acute myeloid leukemia cells from ferroptosis.Mol Cancer. 2025 Jul 21;24(1):201. doi: 10.1186/s12943-025-02394-8. Mol Cancer. 2025. PMID: 40691844 Free PMC article.
-
Gut Microbiome Mediates Ferroptosis Resistance for Colorectal Cancer Development.Cancer Res. 2024 Mar 15;84(6):796-797. doi: 10.1158/0008-5472.CAN-24-0275. Cancer Res. 2024. PMID: 38276975
-
Ferroptosis: a potential therapeutic target in cardio-cerebrovascular diseases.Mol Cell Biochem. 2025 Jul;480(7):4379-4399. doi: 10.1007/s11010-025-05262-7. Epub 2025 Mar 27. Mol Cell Biochem. 2025. PMID: 40148662 Review.
-
Targeting Ferroptosis With Natural Products to Treat Diabetes and Its Complications: Opportunities and Challenges.Phytother Res. 2025 Jul 9. doi: 10.1002/ptr.70028. Online ahead of print. Phytother Res. 2025. PMID: 40634143 Review.
Cited by
-
Prospects for ferroptosis therapies in cancer.Nat Cancer. 2025 Aug;6(8):1326-1336. doi: 10.1038/s43018-025-01037-7. Epub 2025 Aug 18. Nat Cancer. 2025. PMID: 40826242 Review.
-
Xanthosine alleviates myocardial ischemia-reperfusion injury through attenuation of cardiomyocyte ferroptosis.Cell Mol Biol Lett. 2025 Jul 28;30(1):93. doi: 10.1186/s11658-025-00766-y. Cell Mol Biol Lett. 2025. PMID: 40722060 Free PMC article.
References
-
- Seiler A, Schneider M, Forster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Radmark O, Wurst W, et al. (2008). Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab 8, 237–248. 10.1016/j.cmet.2008.07.005. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous